Arrowhead Pharmaceuticals, Inc. (ARWR)
60.73
-2.02
(-3.22%)
USD |
NASDAQ |
Oct 12, 16:00
60.06
-0.67
(-1.10%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Net Income (TTM) : -272.12M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -272.12M |
| March 31, 2026 | -271.86M |
| December 31, 2025 | 233.57M |
| September 30, 2025 | 30.11M |
| June 30, 2025 | -159.35M |
| March 31, 2025 | -154.68M |
| December 31, 2024 | -649.54M |
| September 30, 2024 | -609.69M |
| June 30, 2024 | -547.36M |
| March 31, 2024 | -477.51M |
| December 31, 2023 | -302.84M |
| September 30, 2023 | -209.28M |
| June 30, 2023 | -184.20M |
| March 31, 2023 | -152.12M |
| December 31, 2022 | -155.43M |
| September 30, 2022 | -176.49M |
| June 30, 2022 | -153.93M |
| March 31, 2022 | -111.80M |
| December 31, 2021 | -182.99M |
| September 30, 2021 | -140.85M |
| June 30, 2021 | -125.91M |
| March 31, 2021 | -109.59M |
| December 31, 2020 | -102.61M |
| September 30, 2020 | -84.55M |
| June 30, 2020 | -24.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.531M |
| December 31, 2019 | 53.26M |
| September 30, 2019 | 67.97M |
| June 30, 2019 | 45.51M |
| March 31, 2019 | 9.567M |
| December 31, 2018 | -29.21M |
| September 30, 2018 | -54.45M |
| June 30, 2018 | -54.42M |
| March 31, 2018 | -44.33M |
| December 31, 2017 | -35.49M |
| September 30, 2017 | -34.38M |
| June 30, 2017 | -45.87M |
| March 31, 2017 | -59.77M |
| December 31, 2016 | -74.54M |
| September 30, 2016 | -81.72M |
| June 30, 2016 | -84.24M |
| March 31, 2016 | -80.76M |
| December 31, 2015 | -88.63M |
| September 30, 2015 | -91.94M |
| June 30, 2015 | -89.63M |
| March 31, 2015 | -85.32M |
| December 31, 2014 | -70.62M |
| September 30, 2014 | -58.73M |
| June 30, 2014 | -50.10M |
| March 31, 2014 | -44.65M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Sarepta Therapeutics, Inc. | -266.10M |
| Revolution Medicines, Inc. | -1.768B |
| Intellia Therapeutics, Inc. | -399.98M |
| Denali Therapeutics, Inc. | -511.45M |